{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:06:58Z","timestamp":1778821618234,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,3]],"date-time":"2027-02-03T00:00:00Z","timestamp":1801612800000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["HT9425-24-1-0943"],"award-info":[{"award-number":["HT9425-24-1-0943"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032234","name":"Versiti Blood Research Institute Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032234","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jtha.2025.09.012","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:51:35Z","timestamp":1760140295000},"page":"508-519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preclinical safety and bleeding evaluation in swine for a small interfering RNA-lipid nanoparticle that prevents excess fibrinogen synthesis"],"prefix":"10.1016","volume":"24","author":[{"given":"Monica S.","family":"Seadler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ferraresso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halen M.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura M.","family":"Ketelboeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Badior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William G.","family":"Hayssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber L.","family":"Haugen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo F.","family":"Cau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madelaine","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad","family":"Skaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muskan","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick B.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"de Moya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell R.","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian J.","family":"Kastrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.09.012_bib1","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1182\/blood-2007-10-120543","article-title":"Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents","volume":"111","author":"Crowther","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.09.012_bib2","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1378\/chest.128.4.2203","article-title":"Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis","volume":"128","author":"Mismetti","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2025.09.012_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0377-1237(17)30571-3","article-title":"Low molecular weight heparins","volume":"54","author":"Sharma","year":"1998","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.jtha.2025.09.012_bib4","first-page":"CD008303","article-title":"Thromboprophylaxis for trauma patients","volume":"3","author":"Barrera","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2025.09.012_bib5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199609053351003","article-title":"A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma","volume":"335","author":"Geerts","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.09.012_bib6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archsurg.141.8.790","article-title":"The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials","volume":"141","author":"Leonardi","year":"2006","journal-title":"Arch Surg"},{"key":"10.1016\/j.jtha.2025.09.012_bib7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.0007-1323.2001.01800.x","article-title":"Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery","volume":"88","author":"Mismetti","year":"2001","journal-title":"Br J Surg"},{"key":"10.1016\/j.jtha.2025.09.012_bib8","series-title":"Goldfrank\u2019s Toxicologic Emergencies","article-title":"\u03a1rot\u0430min\u0435","author":"Howland","year":"2019"},{"key":"10.1016\/j.jtha.2025.09.012_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.surg.2023.04.032","article-title":"The efficacy of various Enoxaparin dosing regimens in general surgery patients: a systematic review","volume":"174","author":"Al Tannir","year":"2023","journal-title":"Surgery"},{"key":"10.1016\/j.jtha.2025.09.012_bib10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/phar.2904","article-title":"Multicenter study evaluating target attainment of anti-Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients","volume":"44","author":"Chanas","year":"2024","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jtha.2025.09.012_bib11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/10600280231169523","article-title":"Evaluation of an association between enoxaparin dose per estimated blood volume and clinically relevant bleeding in low-weight trauma patients","volume":"58","author":"Carter","year":"2024","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jtha.2025.09.012_bib12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/TA.0000000000003854","article-title":"Approaches for optimizing venous thromboembolism prevention in injured patients: findings from the consensus conference to implement optimal venous thromboembolism prophylaxis in trauma","volume":"94","author":"Teichman","year":"2023","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.jtha.2025.09.012_bib13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/TA.0000000000000556","article-title":"Can we ever stop worrying about venous thromboembolism after trauma?","volume":"78","author":"Godat","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.jtha.2025.09.012_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/TA.0000000000001046","article-title":"How long should we fear? Long-term risk of venous thromboembolism in patients with traumatic brain injury","volume":"81","author":"Olufajo","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.jtha.2025.09.012_bib15","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1007\/s00268-020-05638-4","article-title":"Is extended-duration (post-hospital discharge) venous thromboembolism chemoprophylaxis safe and efficacious in high-risk surgery patients? A systematic review","volume":"44","author":"Shaikh","year":"2020","journal-title":"World J Surg"},{"key":"10.1016\/j.jtha.2025.09.012_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.thromres.2021.06.010","article-title":"Extended thromboprophylaxis following major abdominal\/pelvic cancer-related surgery: a systematic review and meta-analysis of the literature","volume":"204","author":"Knoll","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.09.012_bib17","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.injury.2022.04.009","article-title":"Pathophysiology in patients with polytrauma","volume":"53","author":"Pape","year":"2022","journal-title":"Injury"},{"key":"10.1016\/j.jtha.2025.09.012_bib18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2018-07-818211","article-title":"The multifaceted role of fibrinogen in tissue injury and inflammation","volume":"133","author":"Luyendyk","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.09.012_bib19","first-page":"557","article-title":"The practice of venous thromboembolism prophylaxis in the major trauma patient","volume":"62","author":"Nathens","year":"2007","journal-title":"J Trauma"},{"key":"10.1016\/j.jtha.2025.09.012_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13049-016-0221-8","article-title":"Fibrinogen levels in trauma patients during the first seven days after fibrinogen concentrate therapy: a retrospective study","volume":"24","author":"Schlimp","year":"2016","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"10.1016\/j.jtha.2025.09.012_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41590-018-0064-8","article-title":"Innate immune responses to trauma","volume":"19","author":"Huber-Lang","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jtha.2025.09.012_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/SHK.0000000000000067","article-title":"Postinjury hyperfibrinogenemia compromises efficacy of heparin-based venous thromboembolism prophylaxis","volume":"41","author":"Harr","year":"2014","journal-title":"Shock"},{"key":"10.1016\/j.jtha.2025.09.012_bib23","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1182\/blood.2021014559","article-title":"Suppression of fibrin(ogen)-driven pathologies in disease models through controlled knockdown by lipid nanoparticle delivery of siRNA","volume":"139","author":"Juang","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.09.012_bib24","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/TA.0000000000004442","article-title":"Suppressing upregulation of fibrinogen after polytrauma mitigates thrombosis in mice","volume":"97","author":"Seadler","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.jtha.2025.09.012_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1182\/blood.2023020805","article-title":"Mice expressing nonpolymerizable fibrinogen have reduced arterial and venous thrombosis with preserved hemostasis","volume":"143","author":"Hur","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.09.012_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101314","article-title":"Protein is expressed in all major organs after intravenous infusion of mRNA-lipid nanoparticles in swine","volume":"32","author":"Ferraresso","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jtha.2025.09.012_bib27","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.addr.2012.07.005","article-title":"A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines","volume":"64","author":"Szebeni","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jtha.2025.09.012_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/ACO.0000000000001265","article-title":"Etiology and management of hypofibrinogenemia in trauma","volume":"36","author":"Nathwani","year":"2023","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.jtha.2025.09.012_bib30","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/0300985811402846","article-title":"Swine as models in biomedical research and toxicology testing","volume":"49","author":"Swindle","year":"2012","journal-title":"Vet Pathol"},{"key":"10.1016\/j.jtha.2025.09.012_bib31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-animal-022114-110815","article-title":"Unraveling the swine genome: implications for human health","volume":"3","author":"Schook","year":"2015","journal-title":"Annu Rev Anim Biosci"},{"key":"10.1016\/j.jtha.2025.09.012_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101258","article-title":"siRNA-mediated reduction of a circulating protein in swine using lipid nanoparticles","volume":"32","author":"Cau","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jtha.2025.09.012_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1515\/ejnm-2015-0011","article-title":"Lessons learned from the porcine CARPA model: constant and variable responses to different nanomedicines and administration protocols","volume":"7","author":"Urbanics","year":"2015","journal-title":"Eur J Nanomed"},{"key":"10.1016\/j.jtha.2025.09.012_bib34","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1021\/acs.molpharmaceut.2c00033","article-title":"Comparison of DLin-MC3-DMA and ALC-0315 for siRNA delivery to hepatocytes and hepatic stellate cells","volume":"19","author":"Ferraresso","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jtha.2025.09.012_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh0027","article-title":"Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A","volume":"16","author":"Strilchuk","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtha.2025.09.012_bib36","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40120-020-00208-1","article-title":"A review of patisiran (ONPATTRO) for the treatment of polyneuropathy in people with hereditary transthyretin amyloidosis","volume":"9","author":"Urits","year":"2020","journal-title":"Neurol Ther"},{"key":"10.1016\/j.jtha.2025.09.012_bib39","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood.2021012537","article-title":"Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with an Fga truncation mutation","volume":"139","author":"Hur","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.09.012_bib38","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2014-08-552000","article-title":"How I use fibrinogen replacement therapy in acquiredbleeding","volume":"125","author":"Levy","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.09.012_bib40","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.3390\/diagnostics11112140","article-title":"Congenital afibrinogenemia and hypofibrinogenemia: laboratory and genetic testing in rare bleeding disorders with life-threatening clinical manifestations and challenging management","volume":"11","author":"Simurda","year":"2021","journal-title":"Diagnostics"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625006038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625006038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:09:18Z","timestamp":1778818158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625006038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1538783625006038"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.09.012","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical safety and bleeding evaluation in swine for a small interfering RNA-lipid nanoparticle that prevents excess fibrinogen synthesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}